Cargando…
Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle
BACKGROUND: Duchenne muscular dystrophy (DMD) is a lethal X-linked muscle wasting disorder caused by the absence of dystrophin, a large cytoskeletal muscle protein. Increasing the levels of the dystrophin-related-protein utrophin is a highly promising therapy for DMD and has been shown to improve pa...
Autores principales: | Kennedy, Tahnee L., Moir, Lee, Hemming, Sarah, Edwards, Ben, Squire, Sarah, Davies, Kay, Guiraud, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655821/ https://www.ncbi.nlm.nih.gov/pubmed/29065908 http://dx.doi.org/10.1186/s13395-017-0139-5 |
Ejemplares similares
-
Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2/mdx Mice
por: Kennedy, Tahnee L., et al.
Publicado: (2018) -
The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019) -
Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD
por: Guiraud, Simon, et al.
Publicado: (2019) -
Glycine administration attenuates progression of dystrophic pathology in prednisolone-treated dystrophin/utrophin null mice
por: Ham, Daniel J., et al.
Publicado: (2019) -
Identification of serum protein biomarkers for utrophin based DMD therapy
por: Guiraud, Simon, et al.
Publicado: (2017)